A Phase 2 Open-Label Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination with Ruxolitinib in Subjects with Myelofibrosis

Project: Research

Project Details

StatusActive
Effective start/end date6/03/20 → 31/12/25

Keywords

  • Clinical Haematology
  • Myelofibrosis
  • Clinical trial